Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision indicator was updated: added Revision v3.3.2 and removed Revision v3.2.0.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding status notice from the page, eliminating a non-critical informational banner. The content about the trial details, eligibility criteria, and results remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedResults information was added to the Study Details page, including the Results First Posted date and posted outcomes. Safety and efficacy data are now available in the study results section.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion updated to v3.0.2; the v3.0.1 reference is removed, and the Back to Top element was deleted.SummaryDifference0.2%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.